Literature DB >> 13799222

Atropine in mongolism.

J M BERG, M W BRANDON, B H KIRMAN.   

Abstract

Entities:  

Keywords:  MONGOLISM/physiology

Mesh：

Substances：

Year:  1959        PMID： 13799222     DOI： 10.1016/s0140-6736(59)90423-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Probing peripheral and central cholinergic system responses.

Authors:  C A Naranjo; J Fourie; N Herrmann; K L Lanctôt; C Birt; K K Yau
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  Atrophine, scopolamine, and glycopyrrolate.

Authors:  A Fassi; M Rosenberg
Journal:  Anesth Prog       Date:  1979 Nov-Dec

4.  Response to atropine in Down's syndrome.

Authors:  G H Mir; G R Cumming
Journal:  Arch Dis Child       Date:  1971-02       Impact factor: 3.791

5.  People with Down's syndrome can be distinguished on the basis of cholinergic dysfunction.

Authors:  B Sacks; S Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-11       Impact factor: 10.154

6.  Sensitive pupil response of early-onset alzheimer's patients to a dilute mixture of cholinergic antagonist and α-Adrenergic stimulant.

Authors:  A Takagi; M Miyao; S Ishihara; H Sakakibara; T Kondo; H Toyoshima; K Kono; A Iguchi
Journal:  Environ Health Prev Med       Date:  1999-04       Impact factor: 3.674

7.  Anaesthetic considerations in Down's syndrome: experience with 100 patients and a review of the literature.

Authors:  M Kobel; R E Creighton; D J Steward
Journal:  Can Anaesth Soc J       Date:  1982-11

8.  Trying to see, failing to focus: near visual impairment in Down syndrome.

Authors:  Lesley Doyle; Kathryn J Saunders; Julie-Anne Little
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.